Royal Bank Of Canada Singular Genomics Systems, Inc. Transaction History

Royal Bank Of Canada

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 05, 2024	BUY	$0.4 - $0.61 $800 - $1,220	2,000 New	2,000 $1,000
Q1 2024 May 15, 2024	SELL	$0.4 - $0.61 $321 - $490	-804 Reduced 28.67%	2,000 $1,000
Q4 2023 Feb 14, 2024	BUY	$0.33 - $0.58 $72 - $127	220 Added 8.51%	2,804 $1,000
Q3 2023 Nov 14, 2023	BUY	$0.37 - $0.99 $1 - $2	3 Added 0.12%	2,584 $0
Q2 2023 Aug 14, 2023	SELL	$0.78 - $1.28 $2,049 - $3,362	-2,627 Reduced 50.44%	2,581 $2,000
Q1 2023 May 15, 2023	SELL	$1.1 - $2.95 $6,431 - $17,248	-5,847 Reduced 52.89%	5,208 $6,000
Q4 2022 Feb 14, 2023	BUY	$1.82 - $2.71 $15,242 - $22,696	8,375 Added 312.5%	11,055 $22,000
Q3 2022 Nov 14, 2022	SELL	$2.5 - $4.73 $14,085 - $26,648	-5,634 Reduced 67.77%	2,680 $7,000
Q2 2022 Aug 15, 2022	BUY	$2.86 - $6.44 $6,921 - $15,584	2,420 Added 41.06%	8,314 $32,000
Q1 2022 May 16, 2022	BUY	$5.94 - $12.09 $18,069 - $36,777	3,042 Added 106.66%	5,894 $37,000
Q4 2021 Feb 14, 2022	BUY	$10.45 - $16.9 $4,911 - $7,942	470 Added 19.73%	2,852 $33,000
Q3 2021 Nov 15, 2021	BUY	$10.9 - $27.63 $14,246 - $36,112	1,307 Added 121.58%	2,382 $27,000
Q2 2021 Aug 16, 2021	BUY	$23.16 - $31.17 $24,897 - $33,507	1,075 New	1,075 $30,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.52B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.